We are live on ! Find out more
IMGN

Immunogen Inc
IMGN

Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

140 hedge funds and large institutions have $1.13B invested in Immunogen Inc in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 44 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $3.78M

70% more capital invested

Capital invested by funds: $665M → $1.13B (+$467M)

2% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 44

0% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 23

1% less funds holding

Funds holding: 141 → 140 (-1)

Holders
140
Holders Change
-1
Holders Change %
-0.71%
% of All Funds
3.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
45
Reduced
44
Closed
23
Calls
$6.99M
Puts
$3.78M
Net Calls
+$3.2M
Net Calls Change
-$1.59M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$33.3M
2
Invesco
Invesco
Georgia
+$18.1M
3
BBA
Baker Bros. Advisors
New York
+$14.5M
4
O
OrbiMed
New York
+$11.3M
5
Franklin Resources
Franklin Resources
California
+$9.6M

Top Sellers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
-$25.4M
2
State Street
State Street
Massachusetts
-$10.6M
3
PCM
Penn Capital Management
Pennsylvania
-$3.33M
4
Barclays
Barclays
United Kingdom
-$3.19M
5
ARTA
A.R.T. Advisors
New York
-$3.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Prudential Financial
26
Prudential Financial
New Jersey
$5.58M +$2.64M +240,000 +162%
TCIM
27
TIAA CREF Investment Management
New York
$4.77M +$60.8K +5,536 +2%
CS
28
Candriam SCA
Luxembourg
$4.31M -$659K -60,000 -17%
BIM
29
BlackRock Investment Management
Delaware
$4.2M +$614K +55,898 +24%
Charles Schwab
30
Charles Schwab
California
$4.07M +$92.5K +8,420 +3%
AllianceBernstein
31
AllianceBernstein
Tennessee
$2.53M +$121K +11,000 +7%
CS
32
Credit Suisse
Switzerland
$2.52M +$515K +46,905 +37%
DCM
33
Driehaus Capital Management
Illinois
$2.5M +$1.91M +173,720 New
LK
34
Lumbard & Kellner
New Hampshire
$2.39M -$19.1K -1,740 -1%
Goldman Sachs
35
Goldman Sachs
New York
$2.31M -$608K -55,344 -26%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$2.26M +$7.94K +723 +0.5%
MIG
37
Mariner Investment Group
New York
$2.21M -$884K -80,500 -34%
Natixis Advisors
38
Natixis Advisors
Massachusetts
$2.21M +$104K +9,440 +7%
Jacobs Levy Equity Management
39
Jacobs Levy Equity Management
New Jersey
$2.13M -$529K -48,200 -25%
Citigroup
40
Citigroup
New York
$2.01M -$132K -11,974 -8%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$1.96M – – –
Citadel Advisors
42
Citadel Advisors
Florida
$1.9M +$453K +41,255 +45%
TI
43
Trexquant Investment
Connecticut
$1.9M +$1.45M +132,100 New
TA
44
Teachers Advisors
New York
$1.86M -$95.8K -8,725 -6%
HCM
45
Highbridge Capital Management
New York
$1.84M +$1.41M +128,255 New
TFCP
46
Twin Focus Capital Partners
Massachusetts
$1.73M -$220K -20,000 -14%
USAA
47
United Services Automobile Association
Texas
$1.72M – – –
SGAM
48
Steinberg Global Asset Management
Florida
$1.69M +$442K +40,259 +52%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.66M -$76.9K -7,000 -6%
American Century Companies
50
American Century Companies
Missouri
$1.51M +$1.15M +104,829 New
1
2
3 4 5

IMGN Hedge Fund Activity: Q2 2015 in Review

140 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q2 2015, worth a combined $1.13B — up 70% from $665M a quarter earlier.

Fund positioning in IMGN was balanced in Q2 2015: 23 funds opened new positions, 23 closed out, 45 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $33.3M. The largest seller was BB Biotech, exiting entirely with an estimated $25.4M sold.

  • 140 institutional investors held Immunogen Inc (IMGN) as of Q2 2015, down from 141 in Q1 2015.
  • Funds reported $1.13B of Immunogen Inc stock for Q2 2015, up 70% quarter-over-quarter.
  • 23 funds opened new Immunogen Inc positions in Q2 2015 and 23 closed out, a net change of 0 holders.
  • The largest Immunogen Inc buyer in Q2 2015 was Millennium Management, an estimated $33.3M added.
  • The largest Immunogen Inc seller in Q2 2015 was BB Biotech, an estimated $25.4M sold.

Based on aggregated 13F filings for Q2 2015.